Lifecare Plum A + Infusion Pump - ANVISA Registration #: 80253310023, 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Hospira Costa Rica Ltd. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1225
  • 날짜
    2012-11-13
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    • Use of the affected product may result in free flow and / or overgrowth of medication, which may lead to adverse events for the patient. It is important for the customer to inspect the equipment before using a cassette by following the instructions below: • Release the cassette compartment by pressing the door latch and fully open the door. • Inspect the door roller visually for evidence of damage or misalignment. • Ensure that the door roller rotates easily when touched with your finger. If the door roller is loose, broken or not found, the infusion pump must be taken out of service and not used until the roller is replaced and / or the door is reassembled. Hospira informs that it has not yet received any reports of an adverse event related to the failure of the door locking roller in Brazil. Additional information or support regarding this issue can be obtained from Tel .: 0800 7733133 or (011) 5508.3100 Extension 3130. Email: tecnovigilância & pharmacovigilancia; @ hospira.com. Access security letter to the clients in: http://portal.anvisa.gov.br/wps/wcm/connect/21c5d3804e4a1a39b4bbb7c09d49251b/Carta_aos_clientes.pdf?MOD=AJPERES UPDATE: 12/01/2014 - until the present moment, it has been fulfilling in a satisfactory way the field actions related to the mentioned product, as proposed in action plan. It should also be noted that according to the reports sent to this ANVISA the company has already updated 4,847 units, which represents 79% of the installed plant in Brazil (total of 6,129 pumps). ////// UPDATE 12/01/2015: RESOLUTION-RE Nº 4.944, OF DECEMBER 26, 2014 Partially repeal Resolution RE 1839 of 05/22/2013, published in DOU Nº 98 of 05/23 / 2013, section 1 pg.65, releasing the importation of infusion pump LIFECARE PLUM A +, registration no. 80253310023, owned by Hospira Produtos Hospitalares (CNPJ 0628311 / 0001-89).
  • 원인
    It has been identified in some plum a + infusion pumps that improper handling of the equipment may cause rupture of the cassette attachment roller located in the door assembly, which may result in free flowing and / or overdose of medication, which may adverse events to the patient.
  • 조치
    Hospira Produtos Hospitalares Ltda. Is sending customers a statement recommending inspection of the settling roller and will redesign the roller to improve strength and reduce ruptures.

Device

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    ANVSANVISA